CompletedNot applicableNCT02175888

The Optimization of Bioavailability From Iron Supplements: Study 1

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Swiss Federal Institute of Technology
Principal Investigator
Diego Moretti, PhD
Human Nutrition Laboratory, ETH Zurich
Intervention
Daily administration of 60 mg iron in form of ferrous sulphate capsules for 14 consecutive days(dietary_supplement)
Enrollment
20 enrolled
Eligibility
18-45 years · FEMALE
Timeline
20152016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02175888 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials